Logo image of CSGP

COSTAR GROUP INC (CSGP) Stock Fundamental Analysis

NASDAQ:CSGP - Nasdaq - US22160N1090 - Common Stock - Currency: USD

81.42  -0.49 (-0.6%)

After market: 81.42 0 (0%)

Fundamental Rating

5

Taking everything into account, CSGP scores 5 out of 10 in our fundamental rating. CSGP was compared to 65 industry peers in the Real Estate Management & Development industry. Both the profitability and the financial health of CSGP get a neutral evaluation. Nothing too spectacular is happening here. CSGP is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CSGP had positive earnings in the past year.
In the past year CSGP had a positive cash flow from operations.
CSGP had positive earnings in each of the past 5 years.
CSGP had a positive operating cash flow in each of the past 5 years.
CSGP Yearly Net Income VS EBIT VS OCF VS FCFCSGP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

The Return On Assets of CSGP (1.12%) is better than 69.23% of its industry peers.
Looking at the Return On Equity, with a value of 1.37%, CSGP is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
CSGP has a Return On Invested Capital of 0.03%. This is comparable to the rest of the industry: CSGP outperforms 56.92% of its industry peers.
CSGP had an Average Return On Invested Capital over the past 3 years of 2.11%. This is below the industry average of 5.47%.
Industry RankSector Rank
ROA 1.12%
ROE 1.37%
ROIC 0.03%
ROA(3y)3.37%
ROA(5y)3.48%
ROE(3y)4.11%
ROE(5y)4.33%
ROIC(3y)2.11%
ROIC(5y)2.77%
CSGP Yearly ROA, ROE, ROICCSGP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

CSGP has a better Profit Margin (4.17%) than 76.92% of its industry peers.
In the last couple of years the Profit Margin of CSGP has declined.
Looking at the Operating Margin, with a value of 0.17%, CSGP is in line with its industry, outperforming 56.92% of the companies in the same industry.
In the last couple of years the Operating Margin of CSGP has declined.
CSGP has a better Gross Margin (79.71%) than 92.31% of its industry peers.
In the last couple of years the Gross Margin of CSGP has remained more or less at the same level.
Industry RankSector Rank
OM 0.17%
PM (TTM) 4.17%
GM 79.71%
OM growth 3Y-80.23%
OM growth 5Y-63.35%
PM growth 3Y-30.42%
PM growth 5Y-25.78%
GM growth 3Y-0.84%
GM growth 5Y0.06%
CSGP Yearly Profit, Operating, Gross MarginsCSGP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

6

2. Health

2.1 Basic Checks

CSGP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CSGP has more shares outstanding
Compared to 5 years ago, CSGP has more shares outstanding
Compared to 1 year ago, CSGP has an improved debt to assets ratio.
CSGP Yearly Shares OutstandingCSGP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CSGP Yearly Total Debt VS Total AssetsCSGP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

CSGP has an Altman-Z score of 12.08. This indicates that CSGP is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 12.08, CSGP belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
CSGP has a Debt/Equity ratio of 0.12. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CSGP (0.12) is better than 75.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Altman-Z 12.08
ROIC/WACC0
WACC8.74%
CSGP Yearly LT Debt VS Equity VS FCFCSGP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

CSGP has a Current Ratio of 6.01. This indicates that CSGP is financially healthy and has no problem in meeting its short term obligations.
CSGP's Current ratio of 6.01 is amongst the best of the industry. CSGP outperforms 87.69% of its industry peers.
A Quick Ratio of 6.01 indicates that CSGP has no problem at all paying its short term obligations.
CSGP has a Quick ratio of 6.01. This is amongst the best in the industry. CSGP outperforms 90.77% of its industry peers.
Industry RankSector Rank
Current Ratio 6.01
Quick Ratio 6.01
CSGP Yearly Current Assets VS Current LiabilitesCSGP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

6

3. Growth

3.1 Past

CSGP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.12%.
Measured over the past years, CSGP shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.71% on average per year.
Looking at the last year, CSGP shows a quite strong growth in Revenue. The Revenue has grown by 11.28% in the last year.
Measured over the past years, CSGP shows a quite strong growth in Revenue. The Revenue has been growing by 14.35% on average per year.
EPS 1Y (TTM)-22.12%
EPS 3Y-14.08%
EPS 5Y-6.71%
EPS Q2Q%90%
Revenue 1Y (TTM)11.28%
Revenue growth 3Y12.07%
Revenue growth 5Y14.35%
Sales Q2Q%11.62%

3.2 Future

The Earnings Per Share is expected to grow by 33.25% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 11.84% on average over the next years. This is quite good.
EPS Next Y13.62%
EPS Next 2Y37.92%
EPS Next 3Y39.9%
EPS Next 5Y33.25%
Revenue Next Year14.71%
Revenue Next 2Y13.53%
Revenue Next 3Y13.37%
Revenue Next 5Y11.84%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CSGP Yearly Revenue VS EstimatesCSGP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
CSGP Yearly EPS VS EstimatesCSGP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 100.52, CSGP can be considered very expensive at the moment.
61.54% of the companies in the same industry are more expensive than CSGP, based on the Price/Earnings ratio.
CSGP's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.28.
A Price/Forward Earnings ratio of 59.45 indicates a quite expensive valuation of CSGP.
Based on the Price/Forward Earnings ratio, CSGP is valued a bit cheaper than 70.77% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CSGP to the average of the S&P500 Index (21.76), we can say CSGP is valued expensively.
Industry RankSector Rank
PE 100.52
Fwd PE 59.45
CSGP Price Earnings VS Forward Price EarningsCSGP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

CSGP's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 188.97
CSGP Per share dataCSGP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CSGP does not grow enough to justify the current Price/Earnings ratio.
CSGP's earnings are expected to grow with 39.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)7.38
PEG (5Y)N/A
EPS Next 2Y37.92%
EPS Next 3Y39.9%

0

5. Dividend

5.1 Amount

CSGP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

COSTAR GROUP INC

NASDAQ:CSGP (7/2/2025, 8:00:00 PM)

After market: 81.42 0 (0%)

81.42

-0.49 (-0.6%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-21 2025-07-21/amc
Inst Owners106.52%
Inst Owner Change4.21%
Ins Owners0.7%
Ins Owner Change13.91%
Market Cap34.35B
Analysts79.09
Price Target89.72 (10.19%)
Short Float %4.03%
Short Ratio5.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)52.49%
Min EPS beat(2)13.92%
Max EPS beat(2)91.05%
EPS beat(4)4
Avg EPS beat(4)49.43%
Min EPS beat(4)13.92%
Max EPS beat(4)91.05%
EPS beat(8)7
Avg EPS beat(8)31.23%
EPS beat(12)11
Avg EPS beat(12)26.73%
EPS beat(16)15
Avg EPS beat(16)23%
Revenue beat(2)0
Avg Revenue beat(2)-1.37%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)-1.07%
Revenue beat(4)0
Avg Revenue beat(4)-1.77%
Min Revenue beat(4)-2.45%
Max Revenue beat(4)-1.07%
Revenue beat(8)0
Avg Revenue beat(8)-1.68%
Revenue beat(12)0
Avg Revenue beat(12)-1.66%
Revenue beat(16)1
Avg Revenue beat(16)-1.47%
PT rev (1m)-0.25%
PT rev (3m)2.7%
EPS NQ rev (1m)1.17%
EPS NQ rev (3m)-26.73%
EPS NY rev (1m)-5.65%
EPS NY rev (3m)-24.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.1%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)3.77%
Valuation
Industry RankSector Rank
PE 100.52
Fwd PE 59.45
P/S 12.22
P/FCF N/A
P/OCF 112.18
P/B 4.01
P/tB 8.75
EV/EBITDA 188.97
EPS(TTM)0.81
EY0.99%
EPS(NY)1.37
Fwd EY1.68%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.73
OCFY0.89%
SpS6.67
BVpS20.28
TBVpS9.31
PEG (NY)7.38
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.12%
ROE 1.37%
ROCE 0.05%
ROIC 0.03%
ROICexc 0.06%
ROICexgc 0.31%
OM 0.17%
PM (TTM) 4.17%
GM 79.71%
FCFM N/A
ROA(3y)3.37%
ROA(5y)3.48%
ROE(3y)4.11%
ROE(5y)4.33%
ROIC(3y)2.11%
ROIC(5y)2.77%
ROICexc(3y)5.52%
ROICexc(5y)6.72%
ROICexgc(3y)37.51%
ROICexgc(5y)65.24%
ROCE(3y)3%
ROCE(5y)3.93%
ROICexcg growth 3Y-84.93%
ROICexcg growth 5Y-68.06%
ROICexc growth 3Y-79.71%
ROICexc growth 5Y-61.67%
OM growth 3Y-80.23%
OM growth 5Y-63.35%
PM growth 3Y-30.42%
PM growth 5Y-25.78%
GM growth 3Y-0.84%
GM growth 5Y0.06%
F-Score5
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF N/A
Debt/EBITDA 6.04
Cap/Depr 209.32%
Cap/Sales 11.98%
Interest Coverage 0.16
Cash Conversion 184.79%
Profit Quality N/A
Current Ratio 6.01
Quick Ratio 6.01
Altman-Z 12.08
F-Score5
WACC8.74%
ROIC/WACC0
Cap/Depr(3y)211.68%
Cap/Depr(5y)162.35%
Cap/Sales(3y)11.14%
Cap/Sales(5y)9.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.12%
EPS 3Y-14.08%
EPS 5Y-6.71%
EPS Q2Q%90%
EPS Next Y13.62%
EPS Next 2Y37.92%
EPS Next 3Y39.9%
EPS Next 5Y33.25%
Revenue 1Y (TTM)11.28%
Revenue growth 3Y12.07%
Revenue growth 5Y14.35%
Sales Q2Q%11.62%
Revenue Next Year14.71%
Revenue Next 2Y13.53%
Revenue Next 3Y13.37%
Revenue Next 5Y11.84%
EBIT growth 1Y-97.13%
EBIT growth 3Y-77.85%
EBIT growth 5Y-58.09%
EBIT Next Year2992.86%
EBIT Next 3Y329.28%
EBIT Next 5Y148.69%
FCF growth 1Y-108.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-35%
OCF growth 3Y-5.8%
OCF growth 5Y-3.03%